About Max
This author has not written his bio yet.
But we are proud to say that Max contributed 638 entries already.
Entries by Max
Newsletter 6
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Here I am with the sixth newsletter from the site. This week it will be more about preclinical than clinical research, but there are still good news! We also have a podcast if you prefer to listen to the newsletter, you can find […]
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
177Lu-PSMA-617 225Ac abiraterone abiraterone acetate ADC ADT AI ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T clinical trial crispr darolutamide docetaxel drug repurposing drug resistance enzalutamide HRR immunotherapy mcrpc metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer oncolytic virus PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data STEAP1 T-cell therapy
Latest Posts
- Newsletter 13/2026 March 29, 2026
- Christopher Sweeney at ASCO GU 2026: Managing mHSPC and How Treatment Now Extends Overall Survival March 28, 2026
- QLS2401: A Trispecific PSMA/STEAP1/CD3 T‑Cell Engager for mCRPC March 27, 2026
- Antibody MQI‑201: Turning Cold Tumors Hot in Advanced Cancer March 26, 2026
